Luo XH - Search Results

1

Recombinant matrix metalloproteinase-14 catalytic domain induces apoptosis in human osteoblastic SaOS-2 cells.

Luo XH, Liao EY, Liao HJ, Jin Y, Zhou HD, Huang G. Luo XH, et al. J Endocrinol Invest. 2003 Nov;26(11):1111-6. doi: 10.1007/BF03345259. J Endocrinol Invest. 2003. PMID: 15008250

2

Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.

Luo XH, Liao EY. Luo XH, et al. Horm Metab Res. 2001 Jul;33(7):383-8. doi: 10.1055/s-2001-16238. Horm Metab Res. 2001. PMID: 11507673

3

Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 in human osteoblast-like cell cultures.

Liao EY, Luo XH. Liao EY, et al. Among authors: luo xh. Endocrine. 2001 Aug;15(3):291-5. doi: 10.1385/ENDO:15:3:291. Endocrine. 2001. PMID: 11762702

4

Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures.

Liao EY, Luo XH, Deng XG, Wu XP. Liao EY, et al. Among authors: luo xh. J Endocrinol Invest. 2001 Dec;24(11):876-81. doi: 10.1007/BF03343945. J Endocrinol Invest. 2001. PMID: 11817712

5

Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells.

Liao EY, Luo XH, Su X. Liao EY, et al. Among authors: luo xh. J Endocrinol Invest. 2002 Oct;25(9):785-90. doi: 10.1007/BF03345513. J Endocrinol Invest. 2002. PMID: 12398237

6

[Differentiation and gene expression of human osteosarcoma cell line MG-63].

Luo XH, Liao EY, Zhou HD. Luo XH, et al. Hunan Yi Ke Da Xue Xue Bao. 2001 Apr 28;26(2):107-10. Hunan Yi Ke Da Xue Xue Bao. 2001. PMID: 12536636 Chinese.

7

[Expression of metalloproteinases and tissue inhibitor of metalloproteinases in human osteoblastic MG-63 cells and normal human osteoblasts].

Luo XH, Liao EY, Deng XG. Luo XH, et al. Hunan Yi Ke Da Xue Xue Bao. 2001 Jun 28;26(3):206, 210. Hunan Yi Ke Da Xue Xue Bao. 2001. PMID: 12536681 Chinese. No abstract available.

8

Effects of different nylestriol/levonorgestrel dosages on bone metabolism in female Sprague-Dawley rats with retinoic acid-induced osteoporosis.

Liao EY, Luo XH, Wang WB, Wu XP, Zhou HD, Dai RC, Liao HJ, Yang C. Liao EY, et al. Among authors: luo xh. Endocr Res. 2003 Feb;29(1):23-42. doi: 10.1081/erc-120018674. Endocr Res. 2003. PMID: 12665316

9

Establishment and evaluation of bone mineral density reference databases appropriate for diagnosis and evaluation of osteoporosis in Chinese women.

Liao EY, Wu XP, Luo XH, Zhang H, Dai RC, Huang G, Wang WB. Liao EY, et al. Among authors: luo xh. J Bone Miner Metab. 2003;21(3):184-92. doi: 10.1007/s007740300029. J Bone Miner Metab. 2003. PMID: 12720054

10

The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis.

Liao EY, Luo XH, Deng XG, Wu XP, Liao HJ, Wang PF, Mao JP, Zhu XP, Huang G, Wei QY. Liao EY, et al. Among authors: luo xh. Endocr Res. 2003 May;29(2):217-26. doi: 10.1081/erc-120022314. Endocr Res. 2003. PMID: 12856809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters